Diabetic Peripheral Neuropathy Associated with Cardiovascular Risk Factors and Glucagon-Like Peptide-1 Concentrations Among Newly Diagnosed Patients with Type 2 Diabetes Mellitus

cardiovascular risk factors 03 medical and health sciences 0302 clinical medicine glucagon-like peptide-1 concentrations RC581-951 newly-diagnosed type 2 diabetes mellitus diabetic peripheral neuropathy Specialties of internal medicine Targets and Therapy [Diabetes, Metabolic Syndrome and Obesity] Original Research 3. Good health
DOI: 10.2147/dmso.s344532 Publication Date: 2022-01-05T18:10:35Z
ABSTRACT
Purpose: This study was aimed at the prevalence, cardiovascular risk factors of diabetic peripheral neuropathy (DPN), and relationship between DPN fasting glucagon-like peptide-1 (fGLP-1) concentrations in newly diagnosed patients with type 2 diabetes mellitus (nT2D). Methods: A cross-sectional descriptive conducted from 2015 to 2020 a population 473 nT2D. Screening for based on United Kingdom screening test. fGLP-1 measured by enzyme-linked immunosorbent assay. Results: The prevalence 26.6%, which mild grade 17.3%, moderate 8.2% severe 1.1% total. Age (OR = 1.73, 95% CI 1.12– 2.67, p 0.012), smoking 1.64, 1.03– 2.62, 0.037), poor control HbA1c 2.66, 1.23– 5.76, 0.01), 24-h urinary albumin (24hUA) 2.49, 1.26– 4.94, 0.007), retinopathy 3.17, 1.46– 6.89, 0.002) significantly increased DPN. In multivariate logistic regression analysis, hypertension 2.96, 1.16– 7.55, 0.023), triglyceride 1.50, 1.11– 2.03, 0.009), 0.85, 0.75– 0.95, 0.005), 0.79, 0.67– 0.93, 0.005) correlated were reduced (p < 0.001). particular, male had lower levels than those without Conclusion: among nT2D 26.6%. Age, smoking, hypertension, control, triglyceride, albumin, 24hUA, associated DPN, negatively 0.005). Keywords: mellitus, neuropathy, factors,
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (60)
CITATIONS (22)